Impact of Innovation on the Performance of Indian Pharmaceutical Industry Using Data Envelopment Analysis

Impact of Innovation on the Performance of Indian Pharmaceutical Industry Using Data Envelopment Analysis
Author :
Publisher :
Total Pages : 0
Release :
ISBN-10 : OCLC:1375249050
ISBN-13 :
Rating : 4/5 (50 Downloads)

Book Synopsis Impact of Innovation on the Performance of Indian Pharmaceutical Industry Using Data Envelopment Analysis by : H.S Pannu

Download or read book Impact of Innovation on the Performance of Indian Pharmaceutical Industry Using Data Envelopment Analysis written by H.S Pannu and published by . This book was released on 2012 with total page 0 pages. Available in PDF, EPUB and Kindle. Book excerpt: In this paper we have used data envelopment analysis (DEA) and econometric models to analyse the impact of research and development and innovation on relative efficiency and productivity change and firm performance in Indian pharmaceutical industry (IPI) between 1998 and 2007 which covers the post-TRIPS (1995) and post Indian Patent Act Amendment (2005) period. Output oriented BCC DEA model and Malmquist productivity index are used to estimate the relative efficiency and productivity change of Indian pharmaceutical companies over the 10 year period. Using econometric models, we have proposed and tested several hypotheses for the IPI and found a positive impact of innovation represented by R&D investment and patents on productivity (sales), market share, exports and ability to attract contract manufacturing among Indian pharmaceutical companies. We also found that the sales growth is additionally driven by DEA efficiency, size, age which have a positive impact on productivity (sales). Export revenue is additionally driven by sales. Within the limitations of the model discussed, contract manufacturing was additionally driven by innovation, size and sales. The company sales growth was additionally driven by export growth and DEA efficiency. The DEA efficiency having a positive impact on sales and sales growth is a new finding as there appears to be no previous investigation to explore this relationship.


Impact of Innovation on the Performance of Indian Pharmaceutical Industry Using Data Envelopment Analysis Related Books

Impact of Innovation on the Performance of Indian Pharmaceutical Industry Using Data Envelopment Analysis
Language: en
Pages: 0
Authors: H.S Pannu
Categories:
Type: BOOK - Published: 2012 - Publisher:

DOWNLOAD EBOOK

In this paper we have used data envelopment analysis (DEA) and econometric models to analyse the impact of research and development and innovation on relative e
Performance of Pharmaceutical Companies in India
Language: en
Pages: 215
Authors: Mainak Mazumdar
Categories: Business & Economics
Type: BOOK - Published: 2012-10-19 - Publisher: Springer Science & Business Media

DOWNLOAD EBOOK

This book explains how government support and institutional set up facilitated the evolution of the Indian pharmaceutical industry and provides an economic anal
The Efficiency and Productivity of Indian Pharmaceutical Companies
Language: en
Pages: 224
Authors: Aas Mohammad
Categories: Business & Economics
Type: BOOK - Published: 2019-09-24 - Publisher: Cambridge Scholars Publishing

DOWNLOAD EBOOK

This book evaluates the performance of the Indian pharmaceutical industry, which plays an important role in economic development. It highlights the role the gov
Relationship between R&D and Financial Performance in Indian Pharmaceutical Industry
Language: en
Pages: 224
Authors: Mithun Nandy
Categories: Business & Economics
Type: BOOK - Published: 2021-12-03 - Publisher: Springer Nature

DOWNLOAD EBOOK

The book provides insight into different research and development (R&D) activities performed by Indian pharmaceutical companies. It describes how R&D activities
The Indian Pharmaceutical Industry - an Overview of Internal Efficiencies Using Data Envelopment Analysis
Language: en
Pages: 0
Authors: Haritha Saranga
Categories:
Type: BOOK - Published: 2014 - Publisher:

DOWNLOAD EBOOK

The Indian Pharmaceutical Industry (IPI) will be going through a major shift in its business model, from the year 2005 onwards, as the existing Process Patent r